Perenteral Nutrition and Oxidative Stress in Preterm Infants
- Conditions
- Preterm Infants
- Interventions
- Other: Photo-protectionOther: Photo-exposure
- Registration Number
- NCT00611546
- Lead Sponsor
- Mansoura University
- Brief Summary
In an effort to decrease the load of peroxides in TPN solutions, multiple studies examined different strategies such as photo-protection, adding multivitamins to the lipid emulsion rather than to the dextrose-amino acid admixture, and adding antioxidants such as glutathione to the TPN solution. However, the role of trace elements as antioxidants, and their interaction with light have not been studied. Also, the impact of TPN-related oxidants on clinical morbidities has not been addressed. Therefore, we aimed in this study of preterm infants to evaluate the role of different components of TPN on urinary peroxides and to examine the biochemical and clinical effects of light protection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Preterm infants included are:
- with gestational age between 28 to 34 weeks
- managed with TPN as part of their care in the NICU
- their postnatal age on enrolment was < 7 days
Infants are excluded if they have:
- Clinical evidence of sepsis, or a positive blood culture on admission
- Hepatobiliary dysfunction
- Persistent metabolic acidosis with base deficit > 10 mEq / L
- Renal impairment (urine output < 1 ml/kg/hour and serum creatinine > 1 mg/dl)
- Disseminated intravascular coagulopathy
- Maternal conditions known to be associated with oxidative stress such as preeclampsia, hypertension and diabetes.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Photo-protection Perenteral nutrition bottle and tubing are protected from light 1 Photo-exposure Perenteral nutrition bottle and tubing are not protected from light
- Primary Outcome Measures
Name Time Method Concentration of peroxides in the urine 48 hours
- Secondary Outcome Measures
Name Time Method Clinical morbidities (death, and bronchopulmonary dysplasia) during hospital stay